Robeco Institutional Asset Management
HRMY icon

Robeco Institutional Asset Management’s Harmony Biosciences HRMY Stock Holding History

Robeco Institutional Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
98,157
-6,154
-6% -$194K ﹤0.01% 593
2026
Q1 		$2.92M Buy
104,311
+57,226
+122% +$1.88M ﹤0.01% 627
2025
Q4 		$1.76M Buy
47,085
+298
+0.6% +$9.8K ﹤0.01% 682
2025
Q3 		$1.29M Hold
46,787
– – ﹤0.01% 732
2025
Q2 		$1.48M Buy
+46,787
New +$1.51M ﹤0.01% 718

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Robeco Institutional Asset Management's HRMY Position: Q2 2026 in Review

Robeco Institutional Asset Management reduced its Harmony Biosciences (HRMY) stake by 5.9% in Q2 2026, selling an estimated $194K and leaving 98,157 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Robeco Institutional Asset Management first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Robeco Institutional Asset Management held 98,157 shares of Harmony Biosciences worth $3.57M as of Q2 2026.
  • Robeco Institutional Asset Management sold 6,154 Harmony Biosciences shares in Q2 2026, an estimated $194K.
  • Harmony Biosciences made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #593 holding.
  • Robeco Institutional Asset Management first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.